Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary P. McLenigan is active.

Publication


Featured researches published by Mary P. McLenigan.


The EMBO Journal | 2006

Controlling the subcellular localization of DNA polymerases ι and η via interactions with ubiquitin

Brian S. Plosky; Antonio E. Vidal; Antonio R. Fernández de Henestrosa; Mary P. McLenigan; John P. McDonald; Samantha Mead; Roger Woodgate

Y‐family DNA polymerases have spacious active sites that can accommodate a wide variety of geometric distortions. As a consequence, they are considerably more error‐prone than high‐fidelity replicases. It is hardly surprising, therefore, that the in vivo activity of these polymerases is tightly regulated, so as to minimize their inadvertent access to primer‐termini. We report here that one such mechanism employed by human cells relies on a specific and direct interaction between DNA polymerases ι and η with ubiquitin (Ub). Indeed, we show that both polymerases interact noncovalently with free polyUb chains, as well as mono‐ubiquitinated proliferating cell nuclear antigen (Ub‐PCNA). Mutants of polι (P692R) and polη (H654A) were isolated that are defective in their interactions with polyUb and Ub‐PCNA, whilst retaining their ability to interact with unmodified PCNA. Interestingly, the polymerase mutants exhibit significantly lower levels of replication foci in response to DNA damage, thereby highlighting the biological importance of the polymerase–Ub interaction in regulating the access of the TLS polymerases to stalled replication forks in vivo.


Molecular and Cellular Biology | 1998

Relationship of the xeroderma pigmentosum group E DNA repair defect to the chromatin and DNA binding proteins UV-DDB and replication protein A

Vesna Rapić Otrin; Isao Kuraoka; Tiziana Nardo; Mary P. McLenigan; André P. M. Eker; Miria Stefanini; Arthur S. Levine; Richard D. Wood

ABSTRACT Cells from complementation groups A through G of the heritable sun-sensitive disorder xeroderma pigmentosum (XP) show defects in nucleotide excision repair of damaged DNA. Proteins representing groups A, B, C, D, F, and G are subunits of the core recognition and incision machinery of repair. XP group E (XP-E) is the mildest form of the disorder, and cells generally show about 50% of the normal repair level. We investigated two protein factors previously implicated in the XP-E defect, UV-damaged DNA binding protein (UV-DDB) and replication protein A (RPA). Three newly identified XP-E cell lines (XP23PV, XP25PV, and a line formerly classified as an XP variant) were defective in UV-DDB binding activity but had levels of RPA in the normal range. The XP-E cell extracts did not display a significant nucleotide excision repair defect in vitro, with either UV-irradiated DNA or a uniquely placed cisplatin lesion used as a substrate. Purified UV-DDB protein did not stimulate repair of naked DNA by DDB− XP-E cell extracts, but microinjection of the protein into DDB−XP-E cells could partially correct the repair defect. RPA stimulated repair in normal, XP-E, or complemented extracts from other XP groups, and so the effect of RPA was not specific for XP-E cell extracts. These data strengthen the connection between XP-E and UV-DDB. Coupled with previous results, the findings suggest that UV-DDB has a role in the repair of DNA in chromatin.


Journal of Biological Chemistry | 2014

The Steric Gate of DNA Polymerase ι Regulates Ribonucleotide Incorporation and Deoxyribonucleotide Fidelity

Katherine A. Donigan; Mary P. McLenigan; Wei Yang; Myron F. Goodman; Roger Woodgate

Background: Accurate bypass of DNA damage by translesion DNA polymerases is critical for cell survival. Results: Wild-type human DNA polymerase ι incorporates ribonucleotides, and a steric gate mutant increases both ribonucleotide incorporation and deoxyribonucleotide selectivity. Conclusion: A single amino acid residue in DNA polymerase ι limits incorporation of ribonucleotides into DNA. Significance: DNA polymerase ι may incorporate ribonucleotides during translesion DNA synthesis. Accurate DNA synthesis in vivo depends on the ability of DNA polymerases to select dNTPs from a nucleotide pool dominated by NTPs. High fidelity replicative polymerases have evolved to efficiently exclude NTPs while copying long stretches of undamaged DNA. However, to bypass DNA damage, cells utilize specialized low fidelity polymerases to perform translesion DNA synthesis (TLS). Of interest is human DNA polymerase ι (pol ι), which has been implicated in TLS of oxidative and UV-induced lesions. Here, we evaluate the ability of pol ι to incorporate NTPs during DNA synthesis. pol ι incorporates and extends NTPs opposite damaged and undamaged template bases in a template-specific manner. The Y39A “steric gate” pol ι mutant is considerably more active in the presence of Mn2+ compared with Mg2+ and exhibits a marked increase in NTP incorporation and extension, and surprisingly, it also exhibits increased dNTP base selectivity. Our results indicate that a single residue in pol ι is able to discriminate between NTPs and dNTPs during DNA synthesis. Because wild-type pol ι incorporates NTPs in a template-specific manner, certain DNA sequences may be “at risk” for elevated mutagenesis during pol ι-dependent TLS. Molecular modeling indicates that the constricted active site of wild-type pol ι becomes more spacious in the Y39A variant. Therefore, the Y39A substitution not only permits incorporation of ribonucleotides but also causes the enzyme to favor faithful Watson-Crick base pairing over mutagenic configurations.


Nucleic Acids Research | 2013

Ubiquitin mediates the physical and functional interaction between human DNA polymerases η and ι

Justyna McIntyre; Antonio E. Vidal; Mary P. McLenigan; Martha G. Bomar; Elena Curti; John P. McDonald; Brian S. Plosky; Eiji Ohashi; Roger Woodgate

Human DNA polymerases η and ι are best characterized for their ability to facilitate translesion DNA synthesis (TLS). Both polymerases (pols) co-localize in ‘replication factories’ in vivo after cells are exposed to ultraviolet light and this co-localization is mediated through a physical interaction between the two TLS pols. We have mapped the polη-ι interacting region to their respective ubiquitin-binding domains (UBZ in polη and UBM1 and UBM2 in polι), and demonstrate that ubiquitination of either TLS polymerase is a prerequisite for their physical and functional interaction. Importantly, while monoubiquitination of polη precludes its ability to interact with proliferating cell nuclear antigen (PCNA), it enhances its interaction with polι. Furthermore, a polι-ubiquitin chimera interacts avidly with both polη and PCNA. Thus, the ubiquitination status of polη, or polι plays a key regulatory function in controlling the protein partners with which each polymerase interacts, and in doing so, determines the efficiency of targeting the respective polymerase to stalled replication forks where they facilitate TLS.


Photochemistry and Photobiology | 1993

DIFFERENTIAL EXPRESSION OF PYRIMIDINE DIMER‐BINDING PROTEINS IN NORMAL AND UV LIGHT‐TREATED VERTEBRATE CELLS

Mary P. McLenigan; Arthur S. Levine; Miroslava Protić

Abstract— The expression of UV damage‐specific DNA‐binding proteins was examined in various phylogenetically distant species with differing DNA repair phenotypes. Two distinct constitutive DNA‐binding activities, one specific for cyclobutane pyrimidine dimers and the other for non‐cyclobutane dimer photoproducts, were detected. The expression of these binding activity was found to be variable throughout the animal kingdom: cold‐blooded vertebrastes show a constitutive cyclobutance dimer‐binding activity excusively, and primates reveal only non‐cyclobutane expression (rather than the constitutive presence)of these UV damage‐specific DNA‐binding activities after UV traeatment correlate with the cells capacity for DNA repair. In addition, cyclobutane pyrimidine dimer‐binding activities could be detected only in cells with eestablished photoreactivating activity


Journal of Experimental Medicine | 2016

DNA polymerase ι functions in the generation of tandem mutations during somatic hypermutation of antibody genes

Robert W. Maul; Thomas MacCarthy; Ekaterina G. Frank; Katherine A. Donigan; Mary P. McLenigan; William Yang; Huseyin Saribasak; Donald Huston; Sabine S. Lange; Roger Woodgate; Patricia J. Gearhart

Gearhart and collaborators address the long-standing question of the roles of error-prone DNA polymerases in somatic hypermutation of antibody genes.


Journal of Biological Chemistry | 2015

Posttranslational Regulation of Human DNA Polymerase ι

Justyna McIntyre; Mary P. McLenigan; Ekaterina G. Frank; Xiaoxia Dai; Wei Yang; Yinsheng Wang; Roger Woodgate

Background: Many proteins are subject to posttranslational regulation, such as ubiquitination. Results: Human DNA polymerase ι (polι) can be monoubiquitinated at >27 unique sites, and exposure to naphthoquinones results in polyubiquitination of polι. Conclusion: Ubiquitination sites are located across the entire polι polypeptide as well as various structural motifs. Significance: Ubiquitination at these sites is likely to alter cellular functions of polι in vivo. Human DNA polymerases (pols) η and ι are Y-family DNA polymerase paralogs that facilitate translesion synthesis past damaged DNA. Both polη and polι can be monoubiquitinated in vivo. Polη has been shown to be ubiquitinated at one primary site. When this site is unavailable, three nearby lysines may become ubiquitinated. In contrast, mass spectrometry analysis of monoubiquitinated polι revealed that it is ubiquitinated at over 27 unique sites. Many of these sites are localized in different functional domains of the protein, including the catalytic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting region, and its ubiquitin binding motifs UBM1 and UBM2. Polι monoubiquitination remains unchanged after cells are exposed to DNA-damaging agents such as UV light (generating UV photoproducts), ethyl methanesulfonate (generating alkylation damage), mitomycin C (generating interstrand cross-links), or potassium bromate (generating direct oxidative DNA damage). However, when exposed to naphthoquinones, such as menadione and plumbagin, which cause indirect oxidative damage through mitochondrial dysfunction, polι becomes transiently polyubiquitinated via Lys11- and Lys48-linked chains of ubiquitin and subsequently targeted for degradation. Polyubiquitination does not occur as a direct result of the perturbation of the redox cycle as no polyubiquitination was observed after treatment with rotenone or antimycin A, which both inhibit mitochondrial electron transport. Interestingly, polyubiquitination was observed after the inhibition of the lysine acetyltransferase KATB3/p300. We hypothesize that the formation of polyubiquitination chains attached to polι occurs via the interplay between lysine acetylation and ubiquitination of ubiquitin itself at Lys11 and Lys48 rather than oxidative damage per se.


DNA Repair | 2017

DNA polymerase ι: The long and the short of it!

Ekaterina G. Frank; Mary P. McLenigan; John P. McDonald; Donald Huston; Samantha Mead; Roger Woodgate

The cDNA encoding human DNA polymerase ι (POLI) was cloned in 1999. At that time, it was believed that the POLI gene encoded a protein of 715 amino acids. Advances in DNA sequencing technologies led to the realization that there is an upstream, in-frame initiation codon that would encode a DNA polymerase ι (polι) protein of 740 amino acids. The extra 25 amino acid region is rich in acidic residues (11/25) and is reasonably conserved in eukaryotes ranging from fish to humans. As a consequence, the curated Reference Sequence (RefSeq) database identified polι as a 740 amino acid protein. However, the existence of the 740 amino acid polι has never been shown experimentally. Using highly specific antibodies to the 25 N-terminal amino acids of polι, we were unable to detect the longer 740 amino acid (ι-long) isoform in western blots. However, trace amounts of the ι-long isoform were detected after enrichment by immunoprecipitation. One might argue that the longer isoform may have a distinct biological function, if it exhibits significant differences in its enzymatic properties from the shorter, well-characterized 715 amino acid polι. We therefore purified and characterized recombinant full-length (740 amino acid) polι-long and compared it to full-length (715 amino acid) polι-short in vitro. The metal ion requirements for optimal catalytic activity differ slightly between ι-long and ι-short, but under optimal conditions, both isoforms exhibit indistinguishable enzymatic properties in vitro. We also report that like ι-short, the ι-long isoform can be monoubiquitinated and polyubiuquitinated in vivo, as well as form damage induced foci in vivo. We conclude that the predominant isoform of DNA polι in human cells is the shorter 715 amino acid protein and that if, or when, expressed, the longer 740 amino acid isoform has identical properties to the considerably more abundant shorter isoform.


Nucleic Acids Research | 2002

Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation.

Vesna Rapić-Otrin; Mary P. McLenigan; Dawn C. Bisi; Martín Gonzalez; Arthur S. Levine


Nucleic Acids Research | 1993

A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein

Masashi Takao; Marija Abramic; Malcolm Moos; Vesna Rapić Otrin; John C. Wootton; Mary P. McLenigan; Arthur S. Levine; Miroslava Protić

Collaboration


Dive into the Mary P. McLenigan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roger Woodgate

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ekaterina G. Frank

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

John P. McDonald

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Miroslava Protić

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antonio E. Vidal

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Brian S. Plosky

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Donald Huston

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Justyna McIntyre

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge